<p>INmune Bio Inc. has amended the employment agreements of its President and Chief Executive, David J. Moss, and its Chief Financial Officer, Cory Ellspermann. David J. Moss’s base salary has been restated to $454,000 per year, and his stock option grant has been updated to 750,000 shares under the company’s stock incentive plan. Cory Ellspermann’s base salary has been restated to $240,000 per year. These changes correct errors in their original agreements dated November 26, 2025. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. INmune Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-117828), on December 03, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

INMB

<p>INmune Bio Inc. has updated the employment agreements for its President and CEO, David J. Moss, and CFO, Cory Ellspermann. Moss's salary is now $454,000 annually with 750,000 stock options, while Ellspermann's salary is $240,000 annually. These changes correct previous errors in their agreements from November 2025.</p>

INmune Bio Inc. Updates Executive Compensation Agreements